|
|
Exchange: |
Over The Counter |
Security
Type: |
N/A |
Shares
Out: |
19,300,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$57.98 - $57.98 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2014-12-22 |
4 |
AS |
$72.72 |
$513,110 |
D/D |
(7,028) |
63,710 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
10,154 |
|
- |
|
Yocher Robert E |
SVP Regulatory Affairs |
|
2014-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
6,920 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
13,186 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
7,997 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2014-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
70,738 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,917 |
10,686 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
3,622 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2014-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,612 |
61,738 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-12-01 |
4 |
AS |
$73.06 |
$109,590 |
D/D |
(1,500) |
7,769 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-12-01 |
4 |
OE |
$22.31 |
$33,465 |
D/D |
1,500 |
9,269 |
|
- |
|
Thomas Robert Bain |
Director |
|
2014-11-14 |
4 |
S |
$80.03 |
$40,015 |
I/I |
(500) |
1,000 |
|
- |
|
Thomas Robert Bain |
Director |
|
2014-11-04 |
4 |
S |
$76.99 |
$76,990 |
D/D |
(1,000) |
1,260 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-11-03 |
4 |
AS |
$76.36 |
$114,540 |
D/D |
(1,500) |
7,769 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-11-03 |
4 |
OE |
$23.08 |
$34,620 |
D/D |
1,500 |
9,269 |
|
- |
|
Strong Mark |
Senior VP, R&D and Quality |
|
2014-10-01 |
4 |
AS |
$76.96 |
$202,020 |
D/D |
(2,625) |
875 |
|
- |
|
Strong Mark |
Senior VP, R&D and Quality |
|
2014-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
3,500 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-09-15 |
4 |
B |
$77.11 |
$11,567 |
I/I |
150 |
150 |
1.99 |
- |
|
Gross Phillip |
10% Owner |
|
2014-09-15 |
4 |
B |
$76.99 |
$5,008,089 |
I/I |
65,000 |
2,006,236 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2014-09-12 |
4 |
B |
$76.34 |
$2,678,210 |
I/I |
34,900 |
1,941,236 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2014-09-12 |
4 |
B |
$76.94 |
$7,694 |
I/I |
100 |
1,906,336 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2014-09-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,906,236 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-09-10 |
4 |
AS |
$78.37 |
$36,442 |
D/D |
(465) |
8,654 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
9,119 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-08-19 |
4 |
S |
$81.51 |
$177,610 |
D/D |
(2,179) |
822 |
|
- |
|
181 Records found
|
|
Page 7 of 8 |
|
|